Clinical Trial Update: CAR-DC for End-Stage IPF [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update indicates the CAR-DC therapy for end-stage idiopathic pulmonary fibrosis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• CAR-DC

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Idiopathic Pulmonary Fibrosis(IPF) | Phase 1 | Status: NOT_YET_RECRUITING